Life Science REIT PLC Cash Flow-to-Debt Ratio
Life Science REIT PLC cash flow-to-debt ratio. Life Science REIT PLC (LABS) has a Cash Flow-to-Debt Ratio of 0.01x as of June 2025, meaning its operating cash flow of GBX958.00K could theoretically repay 0% of its total liabilities (GBX141.89 Million) in one year. Check earnings quality score of Life Science REIT PLC to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Life Science REIT PLC (2021–2024)
Cash flow-to-debt ratio of Life Science REIT PLC from 2021 to 2024. Historical debt coverage capacity for Life Science REIT PLC across 4 annual periods. Check Life Science REIT PLC investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Life Science REIT PLC Cash Flow-to-Debt Ratio by Year (2021–2024)
Life Science REIT PLC cash flow-to-debt ratio by year from 2021 to 2024. Year-by-year debt coverage analysis for Life Science REIT PLC. For the full cash flow conversion analysis, see LABS cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (GBX) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.09x | GBX12.92 Million | GBX138.42 Million | ▲ +55.6% |
| 2023 | 0.06x | GBX7.62 Million | GBX126.96 Million | ▲ +807.7% |
| 2022 | -0.01x | GBX-1.09 Million | GBX128.37 Million | ▼ -102.6% |
| 2021 | 0.33x | GBX3.54 Million | GBX10.82 Million | — |